|Bid||5.38 x 800|
|Ask||5.39 x 1100|
|Day's Range||5.30 - 5.40|
|52 Week Range||1.86 - 7.30|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 8, 2018 - Aug 13, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.50|
Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the Government of Portugal, focused in encouraging the best foreign companies to invest in Portugal.
Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it is set to join the Russell Microcap® Index at the conclusion of the Russell US Indexes annual reconstitution, effective after the US market opens on June 25, according to a preliminary list of additions posted June 8. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attributes.
Amyris (AMRS) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on AXTA sign up now at www.wallstequities.com/registration. Lined up for evaluation this morning are these four stocks: Aemetis Inc. (NASDAQ: AMTX), Amyris Inc. (NASDAQ: AMRS), Axalta Coating Systems Ltd (NYSE: AXTA), and Ecolab Inc. (NYSE: ECL).
LONDON, UK / ACCESSWIRE / May 23, 2018 / If you want access to our free earnings report on LyondellBasell Industries N.V. (NYSE: LYB) ("LyondellBasell"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=LYB. LyondellBasell posted its financial results for first quarter of fiscal year 2018 (Q1 FY18) on April 27, 2018. The multinational chemical Company surpassed analysts' estimates for revenue and earnings for Q1 FY18.
LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want access to our free research report on Amyris, Inc. (NASDAQ: AMRS), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=AMRS as the Company's latest news hit the wire. On May 18, 2018, the Company, which is an industrial bioscience organization, and Chevron Products Co. ("Chevron"), a division of Chevron U.S.A. Inc. (NYSE: CVX), together declared that Amyris' sustainable lubricants joint venture JV Company, Novvi, has entered into an agreement with Chevron to jointly develop and bring to market novel renewable base oil technologies.
Leading biotech firm Amyris, Inc. (AMRS), will host its annual investor conference, BioDisrupt, on May 22, 2018 at the company’s Emeryville headquarters. BioDisrupt gives industry participants and investors an opportunity to gain an up-close view of the company’s pioneering design and development platform for commercializing No Compromise™ molecules, as well as the strategy behind its very successful evolution to focus on high-margin Health and Beauty consumer products & ingredients. Amyris is now one of the fastest growing small-cap companies on NASDAQ and, with Biossance, it has the fastest growing skincare brand in the U.S. Its products include specialty chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals, providing pure and sustainable alternatives to petroleum, plant and animal-based products, with a No Compromise™ approach to cost, performance and availability.
Amyris, Inc. (AMRS), the industrial bioscience company, and Chevron Products Company, a division of Chevron U.S.A. Inc., today announced that Novvi LLC and Chevron have entered into an agreement to jointly develop and bring to market novel renewable base oil technologies. Novvi’s base oil products and technology are recognized by the global lubricant market to deliver sustainable, high-performance solutions in a range of lubricant applications. Since launching its first commercial production in 2014, Novvi has been steadily increasing its base oil production to keep up with robust and growing demand for a variety of automotive, marine and industrial applications.
NEW YORK, May 17, 2018 /PRNewswire/ -- Biossance™, the consumer beauty brand from Amyris, Inc. (AMRS), continues to lead the clean beauty movement with the launch of its new decked-out Clean Beauty Bus, bringing clean skincare products to a wider audience of consumers seeking non-toxic products that meet their needs.
Q1 2018 GAAP revenue of $23.0 million, compared with GAAP revenue of $13.0 million for Q1 2017, representing 77% growth over first quarter of 2017. Q1 2018 Non-GAAP gross margin of $19.0 million, or 83%, ...
NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Amyris, Inc. (NASDAQ: AMRS ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern Time. To listen ...
John Melo is the CEO of Amyris Inc (NASDAQ:AMRS), which has recently grown to a market capitalization of US$290.22M. Recognizing whether CEO incentives are aligned with shareholders is a crucialRead More...
EMERYVILLE, Calif., May 10, 2018-- Amyris, Inc., the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in May 2018.. Oppenheimer ...
Amyris, Inc. (AMRS), the industrial bioscience company, will be presenting its portfolio of commercialized products at Techonomy New York this morning. Amyris has enjoyed the benefit of successfully commercializing more than 10 products since 2012 that have all achieved strong commercial success and will be presenting this track record and its technology platform at this event. Amyris’s combination of No Compromise™ product sales and a value share/royalty business model is delivering strong gross margin performance.
Amyris Inc (NASDAQ:AMRS), a US$334.45M small-cap, is an oil and gas company operating in an industry which has seen a continued decline in oil prices since 2014. However, energy-sector analystsRead More...
EMERYVILLE, Calif., May 08, 2018-- Amyris, Inc. will report financial results for the first quarter ended March 31, 2018 after market close on Monday, May 14, 2018.. The company will hold its quarterly ...
Amyris stock has finally gained some traction after years of struggling, but investors should beware of several notable red flags.
Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. “We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris.
Today, I will be analyzing Amyris Inc’s (NASDAQ:AMRS) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure of a company has been found to affect shareRead More...
EMERYVILLE, Calif., April 03, 2018-- Amyris, Inc., the industrial bioscience company, today announced that management will be presenting at the H.C. Wainwright Global Life Sciences Investment Conference ...
Stock Monitor: Amyris Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 23, 2018 / Active-Investors.com has just released a free earnings report on The Chemours Co. (NYSE: CC ). If you want access ...